Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colitis, Ulcerative × ABX464 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colitis, Ulcerative 1

Interventions

pembrolizumab 1 peficitinib 1 Vitamin E 1 Specimen Handling 1 Nivolumab 1 NX-13 1 Methylprednisolone 1 Medical Marijuana 1 Iron-Dextran Complex 1 Colonoscopy 1 Biopsy 1 Atorvastatin 1 ABX464 1 2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Abivax S.A.

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡